Latest Breaking News On - Sriparna roy - Page 8 : comparemela.com

Moderna wins case in patent dispute with Pfizer, BioNTech over COVID shot

Moderna wins case in patent dispute with Pfizer, BioNTech over COVID shot
yahoo.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from yahoo.com Daily Mail and Mail on Sunday newspapers.

Sriparna royEuropean patent officeAnild silva

Johnson & Johnson to acquire Proteologix for $850 million

Johnson & Johnson on Thursday said it would acquire privately held Proteologix for $850 million in cash, with potential for an additional milestone payment. (Reporting by Sriparna Roy in Bengaluru;.

Sriparna royAnild silva

FDA extends review of Ascendis Pharma s hormone disorder therapy

FDA extends review of Ascendis Pharma s hormone disorder therapy
yahoo.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from yahoo.com Daily Mail and Mail on Sunday newspapers.

Krishna chandra eluriShailesh kuberSriparna royAscendis pharmaUs food drug administrationDrug administration

US FDA recommends healthcare providers switch from Getinge s heart devices

US FDA recommends healthcare providers switch from Getinge s heart devices
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

Shailesh kuberSriparna royDrug administration onDrug administration

Vertex tops Q1 profit estimates on robust demand for cystic fibrosis treatments

(Reuters) - Vertex Pharmaceuticals beat Wall Street estimates for first-quarter profit on Monday, driven by robust uptake for its cystic fibrosis treatments. Cystic fibrosis (CF) - an inherited disorder that causes severe damage to the lungs, diges.

United statesKrishna chandra eluriPratik jainSriparna royVertex pharmaceuticalsU cf foundationWall street